mRNA |
Erlotinib |
GDSC1000 |
pan-cancer |
AAC |
0.22 |
0.0006 |
mRNA |
UNC0638 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0009 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0009 |
mRNA |
AZ628 |
GDSC1000 |
pan-cancer |
AAC |
-0.2 |
0.001 |
mRNA |
Crizotinib |
FIMM |
pan-cancer |
AAC |
0.53 |
0.001 |
mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
0.21 |
0.001 |
mRNA |
THZ-2-102-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
GDC-0941 |
FIMM |
pan-cancer |
AAC |
0.52 |
0.002 |
mRNA |
SNX-2112 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.003 |